ESOTHRIVO Trademark

Trademark Overview

On Wednesday, March 20, 2019, a trademark application was filed for ESOTHRIVO with the United States Patent and Trademark Office. The USPTO has given the ESOTHRIVO trademark a serial number of 88348489. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 24, 2022. This trademark is owned by Shire ViroPharma Incorporated. The ESOTHRIVO trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical products, namely, budesonide oral suspension (BOS) for eosinophilic esophagitis (EoE)
esothrivo

General Information

Serial Number88348489
Word MarkESOTHRIVO
Filing DateWednesday, March 20, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 24, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2019

Trademark Statements

Goods and Servicespharmaceutical products, namely, budesonide oral suspension (BOS) for eosinophilic esophagitis (EoE)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, April 7, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVIROPHARMA BIOLOGICS LLC
Party Type22 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressLEXINGTON, MA 02421
Party NameSHIRE VIROPHARMA LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressLexington, MA 02421
Party NameShire ViroPharma Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameShire ViroPharma Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Monday, October 24, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 24, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 10, 2022SOU EXTENSION 5 GRANTED
Thursday, December 23, 2021SOU EXTENSION 5 FILED
Monday, January 3, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 23, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, September 22, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, July 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 6, 2021SOU EXTENSION 4 GRANTED
Tuesday, July 6, 2021SOU EXTENSION 4 FILED
Tuesday, July 6, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, February 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 1, 2021SOU EXTENSION 3 GRANTED
Monday, February 1, 2021SOU EXTENSION 3 FILED
Monday, February 1, 2021SOU TEAS EXTENSION RECEIVED
Thursday, July 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 28, 2020SOU EXTENSION 2 GRANTED
Tuesday, July 28, 2020SOU EXTENSION 2 FILED
Tuesday, July 28, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, July 7, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 7, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 7, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 7, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 7, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 28, 2020SOU EXTENSION 1 GRANTED
Friday, February 28, 2020SOU EXTENSION 1 FILED
Friday, February 28, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, January 22, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, September 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 17, 2019ASSIGNED TO LIE
Monday, June 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 3, 2019EXAMINER'S AMENDMENT ENTERED
Monday, June 3, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 3, 2019EXAMINERS AMENDMENT E-MAILED
Monday, June 3, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, May 31, 2019ASSIGNED TO EXAMINER
Sunday, April 7, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 23, 2019NEW APPLICATION ENTERED

Related Keywords

esothrivo suspension eosinophilic esophagitis oral budesonide products namely pharmaceutical